Pharmaceuticals, Biotechnology and Life Sciences
Schreiner MediPharm developed the Patch-Safe specialty label for PS Marketing & Outsourcing GmbH, to be used for safe disposal of patches containing active ingredients.
Preclinical study supports Vor’s approach for empowering targeted
immunotherapies through hematopoietic stem cell editing
Paper co-authored by Vor co-founder Dr. Siddhartha Mukherjee
Teva presents 17 posters and three oral presentations at EHF 2019 highlighting long-term and FOCUS Phase IIIb study data The…
MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biopharmaceutical company which specialises in the development of…
Sustained, clinically meaningful bilateral improvement in visual functions 96 weeks after injection Observed bilateral improvement interpreted as clearly superior to…
Technology produces novel heavy chain-only antibodies for bi-specific, single domain antibodies or CAR-Ts CAMBRIDGE, Mass. & ROTTERDAM, The Netherlands, &…
WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX) announced today that Scott Tarriff, Chief Executive Officer,…
WATERTOWN, Mass.–(BUSINESS WIRE)–Lyra Therapeutics, Inc., a clinical-stage biotechnology company developing medicines precisely designed to target ear, nose and throat (ENT)…
KENILWORTH, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24MRK&src=ctag" target="_blank"gt;$MRKlt;/agt; lt;a href="https://twitter.com/hashtag/MRK?src=hash" target="_blank"gt;#MRKlt;/agt;–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)…